GB1317027A - Proteins - Google Patents

Proteins

Info

Publication number
GB1317027A
GB1317027A GB2447770A GB2447770A GB1317027A GB 1317027 A GB1317027 A GB 1317027A GB 2447770 A GB2447770 A GB 2447770A GB 2447770 A GB2447770 A GB 2447770A GB 1317027 A GB1317027 A GB 1317027A
Authority
GB
United Kingdom
Prior art keywords
immunizing
inflammatory
microorganism
composition
neissevia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2447770A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of GB1317027A publication Critical patent/GB1317027A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB2447770A 1969-05-20 1970-05-20 Proteins Expired GB1317027A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6916297A FR2043475A1 (ko) 1969-05-20 1969-05-20

Publications (1)

Publication Number Publication Date
GB1317027A true GB1317027A (en) 1973-05-16

Family

ID=9034297

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2447770A Expired GB1317027A (en) 1969-05-20 1970-05-20 Proteins

Country Status (11)

Country Link
BE (1) BE750641A (ko)
CA (1) CA929476A (ko)
CH (1) CH527272A (ko)
DE (1) DE2024586B2 (ko)
DK (1) DK129466B (ko)
ES (1) ES379815A1 (ko)
FR (1) FR2043475A1 (ko)
GB (1) GB1317027A (ko)
HU (1) HU162857B (ko)
NL (2) NL169754C (ko)
SE (1) SE392904B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2253499B1 (ko) * 1973-12-10 1977-11-04 Fabre Sa Pierre
FR2407262A1 (fr) * 1977-10-27 1979-05-25 Cassenne Lab Sa Nouveaux polysaccharides extraits de corps microbiens d'haemophilus influenzae, procede de preparation et application a titre de medicaments de ces nouveaux produits
NZ188211A (en) * 1977-10-28 1984-09-28 American Cyanamid Co Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens
CH633188A5 (fr) * 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.
US4298596A (en) * 1979-03-29 1981-11-03 Burroughs Wellcome Co. Trypanosoma cruzi glycoprotein vaccine for inducing immunity to Chagas' disease
FR2462477A1 (fr) * 1979-07-31 1981-02-13 Cassenne Lab Sa Nouvelles glycoproteines de klebsiella pneumoniae, procede d'obtention, application a titre de medicaments et compositions les renfermant
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
WO1983003354A1 (en) * 1982-03-30 1983-10-13 Us Army Neisseria gonorrhoeae vaccine
FR2574429B1 (fr) * 1984-12-06 1987-12-11 Roussel Uclaf Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
US4912200A (en) * 1987-05-11 1990-03-27 Schering Corporation Extraction of granulocyte macrophage colony stimulating factor from bacteria
FR2653014B1 (fr) * 1989-10-17 1994-09-16 Roussel Uclaf Utilisation de glycoproteines extraites de bacteries gram (-) pour la fabrication de compositions cosmetiques ou dermatologiques et compositions les renfermant.
EP0556521A1 (en) * 1992-01-09 1993-08-25 Becton, Dickinson and Company Sample processing using disinfectant
EP0552571A1 (en) * 1992-01-09 1993-07-28 Becton, Dickinson and Company Release of intracellular components

Also Published As

Publication number Publication date
SE392904B (sv) 1977-04-25
CH527272A (fr) 1972-08-31
NL7007262A (ko) 1970-11-24
NL169754B (nl) 1982-03-16
BE750641A (fr) 1970-11-20
NL169754C (nl) 1982-08-16
DE2024586C3 (ko) 1980-02-14
NL174267B (nl)
DE2024586B2 (de) 1979-06-07
FR2043475A1 (ko) 1971-02-19
HU162857B (ko) 1973-04-28
DK129466B (da) 1974-10-14
DE2024586A1 (de) 1970-11-26
CA929476A (en) 1973-07-03
DK129466C (ko) 1975-03-10
ES379815A1 (es) 1972-09-01

Similar Documents

Publication Publication Date Title
GB1317027A (en) Proteins
AU1198288A (en) Monoclonal antibodies against melanoma-associated antigens, hybrid cell lines producing these antibodies, and use therefor
IL109381A0 (en) Processes for the isolation, selection and propagation of animal stem cells, genetically modified animals and animal cells, and vectors for the production thereof
MXPA01004503A (es) Alfa 1,2-fucosiltransferasa de helicobacter pylori.
GB1368903A (en) Method of producing pullulan
EP0200909A3 (en) Preparation of protein g and/or fragments thereof
KR880014109A (ko) 암-관련 항원-특이적 인간 면역 글로불린 및 인간 면역 글로불린 을 생산하는 능력을 갖는 인간/인간 하이브리도마
GB1387965A (en) Process for the production of the antibiotic cephemycin
GB1358726A (en) Process for the production of polycarbonates
IE39141L (en) Production of immunological material
GB1465320A (en) Process for the preparation of perfume compositions and perfumed articles
GB1260963A (en) Substituted insulins
GB1428069A (en) Manufacture of licomycin white metal casting alloy and method of making same
GB1518633A (en) Glycopeptide
BE767940A (fr) Procede de preparation du bouillon de culture de macrochampignons, notamment de champignons alimentaires pour la production de l'inoculant industriel et pour la culture
CA2064774A1 (en) Culture methods for producing activated protein c
GB1493542A (en) Production of thermostable lactose
GB1343755A (en) Vaccine for dental caries
GB1486276A (en) Production of n-acylpentapeptides by culture of a strain of streptomyces
ES409978A1 (es) Metodo para la produccion de antibioticos no nitrogenados acidos.
JPS5658499A (en) Reagent for determination of antibody titer.
IE41613L (en) MICROBIOLOGICAL PRODUCTION OF ß-AMYLASE
GB1503851A (en) Process for preparing cephalosporin
GB1332663A (en) Lysosome labilizer preparation thereof and compositions including the same
ES8100809A3 (es) Procedimiento de obtencion de pregna 1,4 dienos

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years